WG Biotech ApS 4
4 · Y-mAbs Therapeutics, Inc. · Filed Jun 10, 2021
Insider Transaction Report
Form 4
WG Biotech ApS
Director10% Owner
Transactions
- Sale
Common Stock
2021-06-08$35.28/sh−33,300$1,174,694→ 4,306,394 total - Sale
Common Stock
2021-06-09$36.19/sh−116,700$4,223,116→ 4,189,694 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $34.50 to $35.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $35.785 to $36.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.